Trial Profile
Open labelled, Randomized, Active-controlled, Parallel-arm, Single-center Study on Effect of Sitagliptin on T2DM Patients on Treatment With Metformin and Insulin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SWIM
- 09 Jun 2015 Primary endpoint has been met. (Reduction in HbA1c from baseline) as per abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 29 May 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.